New research suggests that patients who discontinue blockbuster GLP-1 drugs like semaglutide or tirzepatide tend to recover reduced body mass far faster than those who halt conventional diet and exercise programs.
Findings released in a major medical journal points out that while overweight individuals can lose substantial amounts of their body weight while undergoing treatment, the weight is regained at an average rate of nearly a kilo each month upon discontinuation.
"Individuals using these drugs should be aware of the potential of rapid rebound weight gain when the therapy is stopped," cautioned expert Dr. Susan Jebb.
This pace of recovery means a reversion to pre-treatment weight within about one and a half years.
Analyzing Therapies
The analysis, which looked at 37 of trials involving thousands of patients, contrasted the effects of these new drugs with other pills.
The team note that people who shed pounds through lifestyle changes alone generally see a less rapid creep back—approximately 100 grams monthly—once they finish.
Understanding the Rapid Regain
Doctors suggest the way of the injections accounts for the accelerated regain.
These medications imitate a natural hormone called GLP-1, which controls feelings of fullness.
"Long-term administration of GLP-1 levels several times higher than normal could lead to the system to generate a reduced amount of its endogenous hormone, and could diminish sensitivity to its effects," explained Dr. Adam Collins, a dietetics researcher.
"Discontinuation of this hormone supplement results in hunger is unsuppressed, making overeating far more likely."
A Chronic Condition?
Health authorities suggest the jabs for people with weight-linked medical conditions, accompanied by recommended lifestyle changes.
Many experts argue that, considering the significant potential of weight regain, the therapy might need to be long-term.
This opinion is echoed by pharmaceutical companies, who note that the findings "underscore the long-term character of excess weight," comparing it to managing conditions like diabetes.
User Testimonies
Users who have stopped the medication report a powerful resurgence of hunger.
"It was like a trigger flipping and you're instantly starving," recalled an individual.
This difficulty is exacerbated if individuals have not developed lasting dietary or behavioural modifications during therapy.
Growing Use
Survey data indicate that a significant number of adults in the UK have tried weight-loss jabs in the last 12 months, with demand continuing to grow.
- Use is more common among women than men.
- The middle-aged demographic shows the highest usage rates.
- Many obtain the drugs through private prescriptions rather than public health services.
Finally, clinicians stress that while these medications are effective tools for weight loss, they are not a standalone cure and lasting health benefits likely depends on integrated behavioural management.
